Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival.
暂无分享,去创建一个
Peter Wust | Jens Ricke | Maciej Pech | Günther Gademann | Peter Malfertheiner | Max Seidensticker | P. Malfertheiner | P. Wust | G. Gademann | M. Pech | J. Ricke | G. Wieners | Nils Peters | M. Seidensticker | Konrad Mohnike | Gero Wieners | Franziska Schwartz | Ricarda Ruehl | Enrique Lopez-Hänninen | Thomas Berg | K. Mohnike | N. Peters | E. Lopez-Hänninen | T. Berg | Ricarda Ruehl | F. Schwartz
[1] N. Gilani,et al. Spontaneous regression of hepatocellular carcinoma is possible and might have implications for future therapies. , 2008, European journal of gastroenterology & hepatology.
[2] J. Bruix,et al. Prospective Validation of the Cancer of the Liver Italian Program (CLIP) Score: A New Prognostic System for Patients With Cirrhosis and Hepatocellular Carcinoma , 2000, Hepatology.
[3] P. Wust,et al. Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation. , 2004, Journal of vascular and interventional radiology : JVIR.
[4] M. van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.
[5] P. Bachellier,et al. Surgical resection of hepatocellular carcinoma. Post‐operative outcome and long‐term results in Europe: An overview , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[6] Guy Brock,et al. Experience With More Than 500 Minimally Invasive Hepatic Procedures , 2008, Annals of surgery.
[7] M. Pompili,et al. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre , 2005, Gut.
[8] Alessandro Vitale,et al. Prospective validation of the Barcelona Clinic Liver Cancer staging system. , 2006, Journal of hepatology.
[9] J. Hiatt,et al. Surgical Resection of Hepatocellular Carcinoma , 2008, Cancer journal.
[10] B. Sangro,et al. Spontaneous Regression of Hepatocellular Carcinoma: Three Case Reports and a Categorized Review of the Literature , 2009, Digestive Diseases and Sciences.
[11] P. Wust,et al. [CT-Guided brachytherapy. A novel percutaneous technique for interstitial ablation of liver metastases]. , 2004, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].
[12] L Pagliaro,et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.
[13] J. Llovet,et al. Systematic review: evidence‐based management of hepatocellular carcinoma – an updated analysis of randomized controlled trials , 2006, Alimentary pharmacology & therapeutics.
[14] L. Dawson. The evolving role of radiation therapy in hepatocellular carcinoma. , 2008, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.
[15] Yi-tao Ding,et al. Major complications after radiofrequency ablation for liver tumors: analysis of 255 patients. , 2009, World journal of gastroenterology.
[16] P. Wust,et al. CT-guided interstitial single-fraction brachytherapy of lung tumors: phase I results of a novel technique. , 2005, Chest.
[17] R. T. Ten Haken,et al. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] K. Kagei,et al. Proton Beam Therapy for Hepatocellular Carcinoma: A Retrospective Review of 162 Patients , 2005, Clinical Cancer Research.
[19] C. Lieber,et al. Spontaneous regression of hepatocellular carcinoma. , 1982, Gastroenterology.
[20] M. Reiser,et al. Liver Resection or Combined Chemoembolization and Radiofrequency Ablation Improve Survival in Patients with Hepatocellular Carcinoma , 2007, Digestion.
[21] L. Dawson,et al. Radiation therapy for hepatocellular carcinoma , 2006, Cancer.
[22] J. Bruix,et al. Nonsurgical treatment of hepatocellular carcinoma , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[23] David D. Smith,et al. Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population. , 2008, American journal of surgery.
[24] T. Vogl,et al. Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications. , 2009, European journal of radiology.
[25] T. Hashimoto,et al. Proton Beam Therapy for Hepatocellular Carcinoma Patients with Severe Cirrhosis , 2006, Strahlentherapie und Onkologie.
[26] Zongli Zhang,et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. , 2008, JAMA.
[27] Peter Wust,et al. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. , 2004, International journal of radiation oncology, biology, physics.
[28] S. Fan,et al. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma. , 2009, Journal of hepato-biliary-pancreatic surgery.
[29] J. Bruix,et al. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival , 2003, Hepatology.
[30] T. Hashimoto,et al. Proton beam therapy for hepatocellular carcinoma with limited treatment options , 2006, Cancer.
[31] H. Hasegawa,et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients , 1985, Cancer.
[32] P. Wust,et al. In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiation. , 2005, International journal of radiation oncology, biology, physics.
[33] J. Crowe,et al. Spontaneous Regression of Hepatocellular Carcinoma , 2008, The American Journal of Gastroenterology.
[34] G. Maddern,et al. Radiofrequency ablation of liver tumors: a systematic review. , 2006, Archives of surgery.
[35] K. Ohara,et al. Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis. , 2007, International journal of radiation oncology, biology, physics.
[36] Peter Wust,et al. CT-Guided Interstitial Brachytherapy of Primary and Secondary Lung Malignancies , 2008, Strahlentherapie und Onkologie.
[37] R. Felix,et al. Hepatic arterial port systems for treatment of liver metastases: factors affecting patency and adverse events. , 2004, Journal of vascular and interventional radiology : JVIR.
[38] Y. Akine,et al. Proton beam therapy for aged patients with hepatocellular carcinoma. , 2007, International journal of radiation oncology, biology, physics.
[39] H. Rhim,et al. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies , 2009, Hepatology.
[40] T. Hashimoto,et al. Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus , 2005, Cancer.
[41] L. Lehmkuhl,et al. CT-guided interstitial brachytherapy in the local treatment of extrahepatic, extrapulmonary secondary malignancies , 2006, European Radiology.
[42] Dieter Häussinger,et al. Sorafenib in advanced hepatocellular carcinoma. , 2008, The New England journal of medicine.
[43] V. Mazzaferro,et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.
[44] K. Flaherty,et al. Cell cycle dependent and schedule-dependent antitumor effects of sorafenib combined with radiation. , 2007, Cancer research.
[45] J. Bruix,et al. Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification , 1999, Seminars in liver disease.